相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural killer cell receptors: alterations and therapeutic targeting in malignancies
Gordana Konjevic et al.
IMMUNOLOGIC RESEARCH (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner
L. Fernandez et al.
CANCER LETTERS (2015)
Challenges of cancer therapy with natural killer cells
Hans Klingemann
CYTOTHERAPY (2015)
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
Cariad Chester et al.
FRONTIERS IN IMMUNOLOGY (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Going Back to Class I: MHC and Immunotherapies for Childhood Cancer
Kellie B. Haworth et al.
PEDIATRIC BLOOD & CANCER (2015)
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
Masaru Imamura et al.
BLOOD (2014)
Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
Wing Leung
CLINICAL CANCER RESEARCH (2014)
Cellular immunotherapy strategies for Ewing sarcoma
Claudia Rossig
IMMUNOTHERAPY (2014)
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
Lorenzo Moretta et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2014)
Natural Killer Cell Therapy and Aerosol Interleukin-2 for the Treatment of Osteosarcoma Lung Metastasis
Sergei R. Guma et al.
PEDIATRIC BLOOD & CANCER (2014)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Mechanistic Model of Natural Killer Cell Proliferative Response to IL-15 Receptor Stimulation
Yun M. Zhao et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Complexities of TGF-β Targeted Cancer Therapy
Erin C. Connolly et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Richard B. Womer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Natural Killer Cells: Biology, Physiology and Medicine - Part 1
Yenan T. Bryceson et al.
JOURNAL OF INNATE IMMUNITY (2011)
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Srinivas S. Somanchi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Killing the Killer: Natural Killer Cells to Treat Ewing's Sarcoma
Yong-Oon Ahn et al.
CLINICAL CANCER RESEARCH (2010)
Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
Duck Cho et al.
CLINICAL CANCER RESEARCH (2010)
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
T. Sutlu et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2009)
Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy
Duck Cho et al.
KOREAN JOURNAL OF LABORATORY MEDICINE (2009)
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
Dirk H. J. Verhoeven et al.
MOLECULAR IMMUNOLOGY (2008)
Prognostic factors for local and distant control in Ewing sarcoma family of tumors
C. Rodriguez-Galindo et al.
ANNALS OF ONCOLOGY (2008)
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma
Melinda S. Merchant et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Evidence for NK cell subsets based on chemokine receptor expression
Robert D. Berahovich et al.
JOURNAL OF IMMUNOLOGY (2006)
Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy
MS Staege et al.
PEDIATRIC BLOOD & CANCER (2004)
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
HE Grier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prognostic factors in Ewing's tumor of bone:: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study group
SJ Cotterill et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
